GWAS-related meQTLs across different cancer types
We identified 2,214,458 meQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
QTL type
|
tagSNP
|
Gene position (hg19)
|
Gene
|
p-value
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLCA | cis | rs6964587 | 0.626 | rs34404183 | chr7:91551249 | T/C | cg17063962 | chr7:91808500 | NA | -0.54 | -9.36 | -0.43 | 7.05E-19 | Breast cancer; |
BLCA | cis | rs2297440 | 0.53 | rs34533955 | chr20:62233020 | A/C | cg16989086 | chr20:62203971 | PRIC285 | 0.53 | 7.72 | 0.37 | 1.01E-13 | Glioma;Non-glioblastoma glioma;Glioblastoma; |
BLCA | cis | rs6502050 | 0.835 | rs35038106 | chr17:80180346 | C/T | cg23985595 | chr17:80112537 | CCDC57 | -0.35 | -6.78 | -0.33 | 4.56E-11 | Life satisfaction; |
BLCA | cis | rs12908161 | 1 | rs35524990 | chr15:85258203 | T/C | cg03959625 | chr15:84868606 | LOC388152 | 0.34 | 6.07 | 0.3 | 3.08E-9 | Schizophrenia; |
BLCA | cis | rs4330281 | 0.57 | rs35642812 | chr3:17741409 | C/G | cg20981856 | chr3:17787350 | NA | 0.3 | 6.44 | 0.31 | 3.59E-10 | Schizophrenia; |
BLCA | cis | rs17711722 | 0.727 | rs35850374 | chr7:65357776 | A/G | cg18252515 | chr7:66147081 | NA | -0.42 | -6.25 | -0.31 | 1.08E-9 | Calcium levels; |
BLCA | cis | rs13191362 | 0.935 | rs35942036 | chr6:163163297 | C/T | cg14584255 | chr6:163149320 | PACRG;PARK2 | 0.61 | 7.4 | 0.36 | 8.65E-13 | Body mass index;BMI in non-smokers;Body mass index (joint analysis main effects and physical activity interaction);BMI (adjusted for smoking behaviour);Body mass index in physically active individuals |
BLCA | cis | rs1552244 | 0.882 | rs3755783 | chr3:10029289 | A/G | cg00166722 | chr3:10149974 | C3orf24 | 0.43 | 6.5 | 0.32 | 2.57E-10 | Alzheimer's disease; |
BLCA | cis | rs11864453 | 0.713 | rs3764312 | chr16:72125733 | A/C | cg16558253 | chr16:72132732 | DHX38 | -0.42 | -6.87 | -0.33 | 2.6E-11 | Fibrinogen levels; |
BLCA | cis | rs75804782 | 0.641 | rs3769124 | chr2:239349362 | G/A | cg18131467 | chr2:239335373 | ASB1 | -0.73 | -7.67 | -0.37 | 1.42E-13 | Morning vs. evening chronotype;Chronotype; |
BLCA | cis | rs9649213 | 0.593 | rs3801256 | chr7:97992095 | C/G | cg21770322 | chr7:97807741 | LMTK2 | 0.4 | 8.77 | 0.41 | 6.11E-17 | Prostate cancer (SNP x SNP interaction); |
BLCA | cis | rs4925386 | 0.625 | rs3810550 | chr20:60912117 | C/T | cg09594475 | chr20:60884601 | LAMA5 | 0.48 | 7.88 | 0.37 | 3.42E-14 | Colorectal cancer;Colorectal cancer (SNP x SNP interaction); |
BLCA | cis | rs9649213 | 0.593 | rs3823740 | chr7:97957104 | T/G | cg21770322 | chr7:97807741 | LMTK2 | 0.41 | 9.18 | 0.43 | 2.87E-18 | Prostate cancer (SNP x SNP interaction); |
BLCA | cis | rs6570726 | 0.902 | rs406979 | chr6:145838983 | G/T | cg05347473 | chr6:146136440 | FBXO30 | 0.52 | 8.83 | 0.41 | 4.02E-17 | Lobe attachment (rater-scored or self-reported); |
BLCA | cis | rs7149337 | 1 | rs4261445 | chr14:51723540 | G/A | cg23942311 | chr14:51606299 | NA | 0.49 | 10.79 | 0.48 | 7.34E-24 | Cancer; |